Skip to content

Pilot Study Exploring the Effects of Rhythmic Auditory Stimulation on Gait in People With Motor Incomplete Spinal Cord Injury

Exploring the Effects of Rhythmic Auditory Stimulation on Gait in Motor Incomplete Spinal Cord Injury: A Pilot Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07674927
Enrollment
15
Registered
2026-06-30
Start date
2026-06-01
Completion date
2026-12-31
Last updated
2026-06-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Cord Injury

Brief summary

This pilot study aims to evaluate the feasibility and preliminary efficacy of a wearable rhythmic auditory stimulation system, MedRhythms, for improving gait parameters in patients with motor incomplete SCI. Up to 15 participants aged 18 years or older with non-progressive SCI will be enrolled. Participants will complete supervised gait training using the MedRhythms device twice weekly during regularly scheduled physical therapy sessions over a six-week period. The device uses shoe-mounted sensors and headphones to deliver real-time individualized rhythmic auditory cues based on the user's gait pattern. Primary outcome measures include change in walking speed assessed with the 10-Meter Walk Test. Secondary outcomes include walking endurance measured by the 6-Minute Walk Test, gait parameters obtained through GAITRite analysis, and participant-reported outcomes including the Walking Index for Spinal Cord Injury II (WISCI II) and the SCI Quality of Life Satisfaction with Social Roles and Activities measure. Outcomes will be assessed at baseline, post-intervention (6 weeks), and follow-up (12 weeks). Findings from this study will provide preliminary data on the feasibility and potential clinical impact of rhythmic auditory stimulation as an adjunctive gait rehabilitation strategy for individuals with incomplete SCI.

Interventions

The purpose of this study is to evaluate the feasibility and preliminary efficacy of a rhythmic auditory stimulation device (MedRhythms) in improving gait parameters in individuals with chronic, incomplete spinal cord injury (SCI). Participants will train with the device in a supervised, in-clinic setting at Point West Clinic for 6 weeks, completing 2 sessions per week (12 sessions total)

Sponsors

University of California, Davis
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥18 years old * Language: English or Spanish only * Diagnosis: non-progressive spinal cord lesion; classification as either grade C, D, or E SCI based on American Spinal Injury Association (ASIA) Impairment Scale (AIS) * Able to ambulate at least a contact guard assist level * Time post injury: ≥6 months * Cadence: minimum 40 steps/minute with clear heel strike * Able to consent

Exclusion criteria

* Individuals who use an assistive device and are unable to achieve a 2-point walking pattern (left-right-left-right) with an assistive device * Walks exclusively with a 3-point walking pattern with an assistive device * Ambulation requiring a knee-ankle-foot orthosis (KAFO) * Presence of additional neurological or medical processes that contribute to weakness * Unable to perceive music through the MedRhythyms device

Design outcomes

Primary

MeasureTime frameDescription
10-Meter Walk Test (10MWT)Baseline, post-intervention at 6 weeks and follow-up at 12 weeksMeasure of speed

Secondary

MeasureTime frameDescription
6-Minute Walk Test (6MWT)baseline, post-intervention at 6 weeks, and follow-up at 12 weeksmeasure of endurance

Countries

United States

Contacts

CONTACTAnita M Shammee, DO
amshammee@health.ucdavis.edu15712056604
CONTACTShane Stone, MD
snstone@health.ucdavis.edu
PRINCIPAL_INVESTIGATORShane Stone, MD

UC Davis

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 1, 2026